Impact of Carbohydrate Ingestion Before Urologic Surgery
Impact of Carbohydrate Ingestion Prior to Urologic Surgery to Improve Patient Outcomes
This study is testing if drinking a special carbohydrate drink before urologic surgery can help improve recovery and reduce complications compared to a regular sports drink.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Kansas Medical Center Academic / other |
| Locations | 1 site (Kansas City, Kansas) |
| Trial ID | NCT06057532 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate how consuming a specialized carbohydrate drink before major urologic surgery affects metabolic markers and surgical outcomes. Participants will be randomly assigned to receive either a specialized sports drink or a standard sports drink, with continuous glucose monitoring throughout the surgery and recovery period. The goal is to address the metabolic stress and insulin resistance that can occur during and after surgery, potentially improving patient outcomes and reducing complications.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are scheduled for major urologic surgery lasting more than 4 hours.
Not a fit: Patients with diabetes, those with certain allergies, or individuals who have difficulty swallowing will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved surgical outcomes and reduced complications for patients undergoing major urologic procedures.
How similar studies have performed: Previous studies have shown that carbohydrate loading can reduce surgical stress responses, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * adults, at least 18 years old, * undergoing major urologic surgery (proposed duration more than 4 hours), * must be able to swallow liquid, * must speak English. Exclusion Criteria: * diagnosis of Type 1 or 2 diabetes mellitus * A1C of 6.5% or higher * pregnant or lactating * known allergy to milk, soy, egg, wheat, peanuts, tree nut, * swallowing difficulties
Where this trial is running
Kansas City, Kansas
- University of Kansas Health System — Kansas City, Kansas, United States (Recruiting)
Study contacts
- Principal investigator: Jill M Hamilton-Reeves, PhD — University of Kansas Medical Center
- Study coordinator: Misty D Bechtel
- Email: mbechtel2@kumc.edu
- Phone: 913-945-5037
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.